These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 29617304)

  • 41. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
    J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anaplastic large cell lymphoma ALK-negative clinically mimicking alcoholic hepatitis - a review.
    de Campos FPF; Felipe-Silva A; Zerbini MCN
    Autops Case Rep; 2013; 3(3):11-19. PubMed ID: 31528614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anaplastic Large Cell Lymphoma.
    Medeiros LJ; Elenitoba-Johnson KS
    Am J Clin Pathol; 2007 May; 127(5):707-22. PubMed ID: 17511113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 15-Year-Old Boy with Primary Maxillary Bone Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma Relapsed with Rib Metastasis after Spontaneous Remission of a Maxillary Bone Lesion: A Case Report and Literature Review.
    Aizawa K; Yamazaki F; Shima H; Kurosawa T; Ishikawa T; Nakazawa A; Shimada H
    Case Rep Oncol; 2023; 16(1):308-314. PubMed ID: 37187683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
    Wang C; Chen X; Chen XY; He YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):791-795. PubMed ID: 31594044
    [No Abstract]   [Full Text] [Related]  

  • 46. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
    J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transformation of recurrent ALK-positive anaplastic large-cell lymphoma from common pattern to composite pattern (lymphohistiocytic and small-cell pattern) with a change in CD30 expression.
    Ji L; Liu C; Zhao S
    Int J Hematol; 2023 Jul; 118(1):131-134. PubMed ID: 36735219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature.
    Yang S; Khera P; Wahlgren C; Ho J; Jukic D; Geskin L; English JC
    Am J Clin Dermatol; 2011 Jun; 12(3):203-9. PubMed ID: 21366363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
    D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
    Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of
    Agarwal I; Sabatini L; Alikhan MB
    Front Oncol; 2020; 10():730. PubMed ID: 32457846
    [No Abstract]   [Full Text] [Related]  

  • 51. Anaplastic large cell lymphoma, ALK-positive.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Oishi N; Miranda RN; Feldman AL
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
    ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
    Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variant translocation partners of the anaplastic lymphoma kinase (ALK) gene in two cases of anaplastic large cell lymphoma, identified by inverse cDNA polymerase chain reaction.
    Takeoka K; Okumura A; Honjo G; Ohno H
    J Clin Exp Hematop; 2014; 54(3):225-35. PubMed ID: 25501114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.
    Salaverria I; BeĆ  S; Lopez-Guillermo A; Lespinet V; Pinyol M; Burkhardt B; Lamant L; Zettl A; Horsman D; Gascoyne R; Ott G; Siebert R; Delsol G; Campo E
    Br J Haematol; 2008 Mar; 140(5):516-26. PubMed ID: 18275429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.
    Kutok JL; Aster JC
    J Clin Oncol; 2002 Sep; 20(17):3691-702. PubMed ID: 12202671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Lymphoma (ALCL) Presenting as Perforation Peritonitis: A Case Report and Management Principles.
    Sanker V; Mohamed A; Pranala M; Jadhav C; Tharakan V
    Cureus; 2022 Sep; 14(9):e28738. PubMed ID: 36211108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategy for Pediatric Patients with Relapsed or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Review.
    Noguchi K; Ikawa Y
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
    Shin HJ; Thorson P; Gu J; Katz RL
    Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent ALK-negative anaplastic large T-cell lymphoma presenting as necrotizing vasculitis.
    Nambudiri VE; Aboutalebi A; Granter SR; Saavedra A
    Am J Dermatopathol; 2013 Jun; 35(4):512-6. PubMed ID: 23291583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.